Javelin Pharmaceuticals to Present at the Oppenheimer ''Positioning Investors for the Next Wave in Pain Management’’ Conference on March 6, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (Amex: JAV) today announced that Dr. Curtis Wright IV, MPH , Executive Vice President, Risk Management and Regulatory Affairs, will present at the Oppenheimer Pain Management Investment Conference being held in New York City.
MORE ON THIS TOPIC